Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable

Area of Science:

• Biochemistry
• Cell Biology
• Cancer Metabolism

Background:

• Nicotinamide adenine dinucleotide (NAD) is crucial for cellular metabolism and tumor growth.
• Nicotinamide phosphoribosyltransferase (NAMPT) is a therapeutic target for reducing NAD levels and inhibiting tumors.
• The metabolic response to NAD depletion in cancer cells is not fully understood.

Purpose of the Study:

• To investigate the metabolic heterogeneity of non-small cell lung carcinoma cell lines in response to NAMPT inhibition.
• To determine if cancer cell lines exhibit uniform metabolic adaptation to NAD depletion.

Main Methods:

• Utilized four non-small cell lung carcinoma cell lines with varying sensitivity to the NAMPT inhibitor GNE-617.
• Analyzed metabolic profiles, including glycolysis, oxidative phosphorylation, nucleotide levels, and oxidative stress markers.
• Investigated the role of AMPK activation and the Pentose Phosphate Pathway (PPP) in cellular response.

Main Results:

• NAD levels were reduced in all cell lines, but metabolic responses were heterogeneous.
• Sensitive cell lines (A549, NCI-H1334) reduced glycolysis and nucleotide levels, and increased oxidative phosphorylation.
• Cell lines differed in combating oxidative stress; NCI-H1334 activated AMPK, while A549 utilized the PPP.
• Resistant LC-KJ cells showed higher baseline NADPH and delayed NAD reduction.

Conclusions:

• Cancer cell lines display significant metabolic heterogeneity in response to NAD depletion.
• The intrinsic molecular and genetic framework of cancer cells influences their metabolic adaptation to NAMPT inhibition.
• This heterogeneity presents challenges and opportunities for targeted cancer therapies involving NAMPT inhibitors.